0.8 ML anifrolumab-fnia 150 MG/ML Prefilled Syringe [Saphnelo]
- RxCUI
- 2741482
- RxNorm name
- 0.8 ML anifrolumab-fnia 150 MG/ML Prefilled Syringe [Saphnelo]
- Display name
- 0.8 ML anifrolumab-fnia 150 MG/ML Prefilled Syringe [Saphnelo]
- Full name
- 0.8 ML anifrolumab-fnia 150 MG/ML Prefilled Syringe [Saphnelo]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SAPHNELO | ANIFROLUMAB-FNIA | AstraZeneca Pharmaceuticals LP | d6203302-2128-41a7-b0b4-0e6c0704d4dc | 2026-04-24 | Warnings, Adverse reactions | 2741482 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d6203302-2128-41a7-b0b4-0e6c0704d4dc | Saphnelo 120 MG in 0.8 ML Prefilled Syringe [PSN] · 0.8 ML anifrolumab-fnia 150 MG/ML Prefilled Syringe [Saphnelo] [SBD] · Saphnelo 120 MG per 0.8 ML Prefilled Syringe [SY] | 3 | 15 | These highlights do not include all the information needed to use SAPHNELO ® safely and effectively. See full prescribing information for SAPHNELO. SAPHNELO (anifrolumab-fnia) injection, for intravenous, or subcutaneous use Initial U.S. Approval: 2021 | 20260424 |